US Stock MarketDetailed Quotes
CDTX Cidara Therapeutics
- 20.5300
- -2.2800-10.00%
Close Dec 18 16:00 ET
- 19.5800
- -0.9500-4.63%
Pre 04:33 ET
224.58MMarket Cap-0.89P/E (TTM)
22.7800High19.2400Low90.51KVolume22.4700Open22.8100Pre Close1.86MTurnover1.83%Turnover RatioLossP/E (Static)10.94MShares24.990052wk High1.94P/B101.60MFloat Cap10.000052wk Low--Dividend TTM4.95MShs Float382.6000Historical High--Div YieldTTM15.52%Amplitude8.0000Historical Low20.5480Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Cidara Therapeutics Stock Forum
RBC Capital Initiates Coverage On Cidara Therapeutics with Outperform Rating, Announces Price Target of $34
Cidara Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(9.2%),TCG Crossover Fund II, L.P.(9.2%), etc.
1. Not all of these stocks will go up. Everything relies on market sentiment/buy pressure, the satanic shorts including dark pool.
2. The SI CTB and shorts availability are based on 11/29 data and may get updated Monday.
3. NEVER open position without momentum.
4. If you are expecting all stocks to be a runner,then you are set for failure, losses, and bagholding. Not all good news run and not all bad news crash the pri...
Cidara Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.
Cash available will sustain the operations for 24 months (exclude 105mil private placement). Upcoming catalyst September 2025.
No comment yet